Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Clinical Endocrinology
|
December 1, 1987
Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion
O Serri
Hormone Research
|
January 1, 1987
Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia
O Serri
The New England Journal of Medicine
|
October 6, 1994
Progress in the management of hyperprolactinemia
O Serri
Neuroendocrinology
|
January 1, 1986
Somatotroph responsiveness to low dose dopamine infusion in normal subjects and acromegalic patients
O Serri
Hormone Research
|
January 1, 1989
Temporal changes in prolactin and corticosterone response during chronic treatment with d-fenfluramine
O Serri, E Rasio
L'Union Medicale Du Canada
|
January 1, 1992
[Cushing's syndrome and pregnancy: apropos of a case and review of the literature]
M Kacem, O Serri
Metabolism: Clinical and Experimental
|
October 1, 1995
Intervention in diabetic vascular disease by modulation of growth factors
O Serri, G Renier
Neuroendocrinology
|
August 1, 1987
Growth hormone responsiveness in vivo and in vitro to growth hormone releasing factor in the spontaneously diabetic BB Wistar rat
O Serri, P Brazeau
Neuroendocrinology
|
November 1, 1991
Effects of acute and prolonged glucose excess on growth hormone release by cultured rat anterior pituitary cells
G Renier, O Serri
Canadian Journal of Physiology and Pharmacology
|
December 1, 1987
The effect of d-fenfluramine on anterior pituitary hormone release in the rat: in vivo and in vitro studies
O Serri, E Rasio
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Clinical Endocrinology
|
December 1, 1987
Growth hormone releasing factor stimulates and somatostatin inhibits prolactin release from human mixed somatotroph-lactotroph adenomas in perifusion
O Serri
Hormone Research
|
January 1, 1987
Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia
O Serri
The New England Journal of Medicine
|
October 6, 1994
Progress in the management of hyperprolactinemia
O Serri
Neuroendocrinology
|
January 1, 1986
Somatotroph responsiveness to low dose dopamine infusion in normal subjects and acromegalic patients
O Serri
Hormone Research
|
January 1, 1989
Temporal changes in prolactin and corticosterone response during chronic treatment with d-fenfluramine
O Serri, E Rasio
L'Union Medicale Du Canada
|
January 1, 1992
[Cushing's syndrome and pregnancy: apropos of a case and review of the literature]
M Kacem, O Serri
Metabolism: Clinical and Experimental
|
October 1, 1995
Intervention in diabetic vascular disease by modulation of growth factors
O Serri, G Renier
Neuroendocrinology
|
August 1, 1987
Growth hormone responsiveness in vivo and in vitro to growth hormone releasing factor in the spontaneously diabetic BB Wistar rat
O Serri, P Brazeau
Neuroendocrinology
|
November 1, 1991
Effects of acute and prolonged glucose excess on growth hormone release by cultured rat anterior pituitary cells
G Renier, O Serri
Canadian Journal of Physiology and Pharmacology
|
December 1, 1987
The effect of d-fenfluramine on anterior pituitary hormone release in the rat: in vivo and in vitro studies
O Serri, E Rasio
Page
of 6